OpenAI-backed biotech firm Chai Discovery raises $130M Series B at...

ha condiviso un link

2025-12-16 00:01:30

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.

0 Commenti 0 condivisioni 2 Views